Home » UPC decisions » Regional Division » Nordic-Baltic Regional Division » Nordic-Baltic Regional Division, December 11, 2024, order on adjournment of oral hearing, UPC_CFI_380/2023, ACT_582093/2023

Nordic-Baltic Regional Division, December 11, 2024, order on adjournment of oral hearing, UPC_CFI_380/2023, ACT_582093/2023

3 min Reading time

Key takeaways

The request to stay the proceedings shall be decided on the basis of R. 295(a) RoP in conjunction with Art. 33(10) UPCA. In exercising its discretion the court shall take into account the interests of the parties and the relevant circumstances of the case. Furthermore, an effort should be made to avoid contradictory decisions by the UPC and the EPO.

Proceedings before the UPC shall be conducted in a way which will normally allow the final oral hearing at first instance to take place within one year. If the adjournment of the oral hearing would further dealy the proceedings, even though the oral hearing will already only take place over a year after the statement of claim was served, the court may also decide against an adjournment. However, in this case the parties shall inform the court about the decision of the EPO and the court can still take this into account after the oral hearing.

Division

Nordic-Baltic Regional Division

UPC number

UPC_CFI_380/2023, ACT_582093/2023, ORD_65290/2024

Type of proceedings

Infringement action, with Counetrclaims for revocation

Parties

Applicants/Defendants: MERIL LIFE SCIENCES PVT LIMITED et. al

Respondent/Claimant: EDWARDS LIFESCIENCES CORPORATION

Patent(s)

EP 3 769 722

Body of legislation / Rules

Rule 295(a) RoP, Art. 33(10) UPCA


Was the article helpful?


Categories


Tags

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field